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Objective. To assess hospital and geographic variability in 30-day mortality after sur-
gery for CRC and examine the extent to which sociodemographic, area-level, clinical,
tumor, treatment, and hospital characteristics were associated with increased likelihood
of 30-day mortality in a population-based sample of older CRC patients.
Data Sources/Study Setting. Linked Surveillance Epidemiology End Results
(SEER) and Medicare data from 47,459 CRC patients aged 66 years or older who
underwent surgical resection between 2000 and 2005, resided in 13,182 census tracts,
and were treated in 1,447 hospitals.
Study Design. An observational study using multilevel logistic regression to identify
hospital- and patient-level predictors of and variability in 30-day mortality.
Data Collection/Extraction Methods. We extracted sociodemographic, clinical,
tumor, treatment, hospital, and geographic characteristics from Medicare claims,
SEER, and census data.
Principal Findings. Of 47,459 CRC patients, 6.6 percent died within 30 days
following surgery. Adjusted variability in 30-day mortality existed across residential
census tracts (predicted mortality range: 2.7–12.3 percent) and hospitals (predicted
mortality range: 2.5–10.5 percent). Higher risk of death within 30 days was observed
for CRC patients age 85+ (12.7 percent), census-tract poverty rate >20 percent
(8.0 percent), two or more comorbid conditions (8.8 percent), stage IV at diagnosis
(15.1 percent), undifferentiated tumors (11.6 percent), and emergency surgery (12.8
percent).
Conclusions. Substantial, but similar variability was observed across census tracts
and hospitals in 30-day mortality following surgery for CRC in patients 66 years and
older. Risk of 30-day mortality is driven not only by patient and hospital characteristics
but also by larger social and economic factors that characterize geographic areas.
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In the current health care reform environment of increasing transparency
and accountability, postoperative mortality rates to assess hospital quality
have gained increasing attention and importance. For example, the Centers
for Medicare & Medicaid Services (CMS) and the Agency for Healthcare
Research and Quality publicly report as a measure of quality of care the
30-day mortality rates for acute myocardial infarction, heart failure, pneu-
monia, and selected medical conditions on their website (www.hospitalcom-
pare.hhs.gov). In addition, CMS plans to use 30-day mortality measures in
its Hospital Inpatient Value-Based Purchasing program (Centers for Medi-
care & Medicaid Services 2011). Variability in 30-day mortality has been
frequently used as a quality measure for cancer and noncancer care (Insti-
tute of Medicine 1999). Quality of cancer care may be improved by reduc-
ing variation in underuse of effective and necessary care; variation that
indicates misuse of preference-sensitive care (i.e., care that offers equivalent
options to be chosen among by the patient); and variation that indicates
overuse of supply-sensitive care (i.e., care inﬂuenced by medical capacity;
Wennberg 2010). Examining and reducing variability in medical care has
been an important policy consideration for almost 30 years (Wennberg
1999; Tanenbaum 2013).
Colorectal cancer (CRC) is the second leading cause of cancer deaths in
the United States, accounting for an estimated 103,170 new cases and 51,690
deaths in 2012 (American Cancer Society 2012). Elderly patients with CRC
aremore likely to die than younger patients, especially during the 30-day post-
operative period (Fazio et al. 2004; Davila et al. 2005; Dekker et al. 2011;
Morris et al. 2011; Panis et al. 2011). Variation in mortality rates among
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subgroups of CRC patients is especially pronounced in the ﬁrst month after
surgery (Moller et al. 2011). Studies examining variation in 30-day mortality
in CRC have predominantly focused on hospital volume (Meyerhardt et al.
2003; Schrag et al. 2003; Iversen et al. 2007). Less attention has been paid to
other potentially important sociodemographic factors, including residential
location and information regarding hospital characteristics. Area characteris-
tics of the patient’s residential location could inﬂuence 30-day mortality
through various mechanisms such as health-system factors, lifestyle factors,
tumor biology, and comorbidity (Polite, Dignam, and Olopade 2006).
Identiﬁcation of other factors contributing to variation in 30-day mortality
rates following CRC surgery may help to identify best practices to reduce
postoperative mortality among elderly patients at the hospital level. Interven-
tions may also focus on geographic areas since they are out of the control of
hospitals and may help explain apparent differences in outcomes among
hospitals. Therefore, we sought to describe variation in 30-day mortality
across hospitals and geographic areas while adjusting for the known effects of
patient sociodemographic, clinical, tumor, treatment, and hospital characteris-
tics associated with an increased likelihood of 30-day all-cause mortality after
CRC surgery. We hypothesized that these variables would help explain the
hospital and geographic variability in 30-day all-cause mortality in CRC
patients.
MATERIALS ANDMETHODS
Data Sources
We obtained data from an existing linkage of the 2000–2005 National Cancer
Institute’s Surveillance, Epidemiology, and End Results (SEER) program data
with 1999–2005 Medicare claims ﬁles from CMS. Linked SEER-Medicare
data provide a rich source of information on Medicare patients included in
SEER, a nationally representative collection of population-based cancer regis-
tries (Warren et al. 2002). Ninety-four percent of cancer patients reported to
SEER aged 65 years or older has been successfully linked with Medicare data
(Warren et al. 2002). This study included data from the following SEER regis-
tries (San Francisco, San Jose, Los Angeles, great California area, Connecticut,
Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, rural Georgia,
Kentucky, Louisiana, and New Jersey) representing approximately 14 percent
of the U.S. population. The study was reviewed by the Institutional Review
Board atWashington University and determined to be exempt from oversight.
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Study Population
We conducted a retrospective cohort study with all-cause mortality within
30 days following surgery (yes, no) as the outcome of interest. Deaths occur-
ring prior to and after discharge were included. We selected all patients
66 years of age or older with a ﬁrst primary in situ or invasive colon or rectal
cancer diagnosis from 2000 through 2005 and who had both Medicare Part A
and Part B coverage and were in fee-for-service Medicare during this period.
We included only patients at least 66 years of age to allow for 1 year of com-
plete claims data prior to diagnosis to determine comorbidity. We excluded
patients who had only autopsy or death certiﬁcate records of their cancer diag-
nosis in SEER or who were members of a Health Maintenance Organization
because these patients lack complete claims data or follow-up data on vital sta-
tus. A total of 89,301 CRC patients aged 66 or older were identiﬁed and
41,842 were excluded for various reasons (i.e., having HMO coverage
n = 22,561, not havingMedicare A& B n = 5,535, death certiﬁcate or autopsy
only n = 1,396, no surgery identiﬁed n = 14,119, missing data on covariates
n = 2,500) leaving 47,459 CRC patients available for analysis. Patients may
have been excluded for more than one reason.
Study Variables
We used Medicare data to determine vital status within 30 days of surgery,
because SEER data provide only month and year of death. Treatments for
CRC included deﬁnitive surgery, chemotherapy, or radiotherapy. Treat-
ments were measured by searching inpatient, outpatient, and carrier claims
using previously identiﬁed Healthcare Common Procedure Coding System
and/or International Classiﬁcation of Diseases (version 9) codes (Warren
et al. 2008). The date on which the most extensive surgery was performed
was used as the date of deﬁnitive surgery, hereafter referred to only as
“surgery.”
Covariates
We selected variables associated with hospital and census-tract variation and
variables associated with 30-day mortality based on previous studies and a
conceptual model that includes various types of characteristics affecting
quality of care (Donabedian 1988; Hodgson, Fuchs, and Ayanian 2001; Polite,
Dignam, and Olopade 2006). This multilevel conceptual model consists of
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individual-, hospital-, provider-, and area-level characteristics predicting
30-day mortality among CRC patients.
Patient sociodemographic characteristics included sex, race/ethnicity, com-
orbidity, eligibility for both Medicare and Medicaid (dual eligibility), age
group, and year of diagnosis. To measure comorbidity, we searched inpatient
or carrier claims for multiple chronic conditions occurring 1–12 months prior
to diagnosis using the Klabunde adaptation of the Charlson comorbidity
index (National Cancer Institute 2011). It uses a minimum of two claims 30
days apart to validate the comorbidity occurrence. We further classiﬁed com-
orbidity as none, one, or two or more. We limited the patients in our analysis
to those aged 66 years and older to ensure all patients had full year look-back
period. Dual eligibility was deﬁned as eligibility for Medicaid coverage for at
least 1 month during the year before diagnosis.
Area-level characteristics included percentage of the population living in
poverty in the patient’s census tract. Each patient’s residential address at time
of diagnosis was matched to its respective census tract as deﬁned for the 2000
U.S. Census.
Hospital characteristics, where the patient’s surgery took place, included
number of hospital beds, number of CRC surgeries performed, and whether it
was a teaching hospital or not, which were obtained from the Healthcare Cost
Report and the Provider of Service ﬁles fromCMS. The hospital’s surgery vol-
ume was calculated using the number of CRC surgeries performed during the
study period.
Tumor characteristics included American Joint Commission on Cancer
(AJCC) stage, tumor grade, tumor location, and histology. The location of the
tumor was classiﬁed as proximal colon (cecum, ascending); transverse colon
(hepatic ﬂexure, transverse colon, splenic ﬂexure); distal colon (descending
and sigmoid colon); or rectosigmoid junction or rectum.
Treatment characteristics within 30 days of the index surgery included
emergency surgery and type of surgery (Warren et al. 2008).
Statistical Analysis
Univariate associations between 30-day mortality and each covariate were
tested using Chi-square tests. We also examined intercorrelations among the
predictor variables. A multi-level, cross-classiﬁed logistic model for a discrete
response variable was used to describe the variation across hospitals and
census tracts to account for nesting of CRC patients within hospitals and
within census tracts of their residence (Snijders and Bosker 1999). This nesting
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structure allows patients from the same census tract to be treated at different
hospitals and allows for the fact that different hospitals could treat patients
from the same tracts. In essence, this structure does not impose any relation-
ship between hospitals and tracts. Adjusted odds ratios and their 95 percent
conﬁdence intervals were calculated based on all variables that were entered
into the multivariable model. Model ﬁt was based on the Deviance Informa-
tion Criterion (DIC), with lower values indicating better ﬁt.
The median odds ratio (MOR) and interquartile odds ratio (IOR) were
calculated based on this multi-level model to facilitate interpretation of the
variability among census tracts and hospitals on a scale that is directly compa-
rable with the odds ratios that are used for the other variables in the study
(Merlo et al. 2006). The MOR and IOR are based on the random effects vari-
ance component (V) from the logistic regression model: MOR ¼
expð0:95 ﬃﬃﬃﬃVp Þ and IOR ¼ expð2:30 ﬃﬃﬃﬃVp Þ. The MOR can be interpreted as the
median value of the ratio of predicted odds of 30-day mortality for two
patients randomly selected from different census tracts (or hospitals) but with
equivalent covariates. If the MOR is equal to 1, it indicates no variation in
30-day mortality across census tracts or hospitals. The IOR reﬂects the differ-
ence in likelihood of 30-day mortality between 25 percent of all patients from
census tracts or hospitals with the highest risk in 30-day mortality and 25
percent of all patients from census tracts or hospitals with the lowest risk in
30-day mortality. We obtained the standard errors of the census-tract-level
and hospital-level variances to compute the 95 percent credible interval for
the MORs and IORs using Markov Chain Monte Carlo methods in the
Bayesian multilevel models.
In addition, we calculated census-tract-level predicted values for 30-day
mortality to describe the geographic and hospital variability. These predicted
values for 30-day mortality were computed based on the multivariable model
by averaging the patient-level predicted probabilities for all patients who
resided in that census tract. Only census tracts with at least 20 patients were
used in order to increase precision of the estimates. Similarly, we calculated
hospital-level predicted values for 30-day mortality to describe the variability
by randomly selecting 10 hospitals from hospitals with the following patient
volume: 20–49, 50–99, 100 or more patients. Hospital-level predicted values
for 30-day mortality were computed based on the multivariable model by
averaging the patient-level predicted probabilities for all patients who were
treated at that hospital.
Data were managed and analyzed in SAS (version 9.1, SAS Institute
Inc., Cary, NC). The Bayesian analysis for the cross-classiﬁed model was
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performed using WinBUGS (version 1.4.3). After 5,000 burn-in iterations,
5,000 additional iterations were kept for parameter estimates.
RESULTS
Overall, 47,459 patients underwent CRC surgery from 2000 through 2005
and were included in the analysis. Patients resided in 13,182 different census
tracts and were treated at 1,447 different hospitals. Of these 47,459 patients,
3,126 (6.6 percent) died within 30 days following surgery; 63.4 percent died
from any cause during their hospitalization for CRC surgery and 59.7 percent
died of CRC. Table 1 shows that most CRC patients were white (85.8
percent), not participating in Medicaid (83.5 percent), younger than 85 (81.4
percent), and living in census tracts where <10 percent of the population lived
below the federal poverty rate (57.9 percent). Little difference existed in the
mean census-tract poverty rate between the SEER study areas (13.4 percent)
and the overall ﬁndings reported for the United States (13.5 percent). Table 1
summarizes the characteristics of CRC patients who died within 30 days after
surgery.
Statistically signiﬁcant variability in 30-day mortality was present across
census tracts and hospitals in unadjusted analysis (Table 2). For patients with
CRC, variability across census-tracts and hospitals was similar in magnitude;
theMORwas about 1.4, which corresponds to the median value of the relative
odds of 30-day mortality between two randomly chosen census tracts for
CRC patients. Variability in 30-day mortality was similar across census tracts
and hospitals in unadjusted analysis.
In multivariable analysis (Table 3), several characteristics were indepen-
dently associated with higher odds of 30-day mortality, including sociodemo-
graphics (being male, having at least one comorbid condition, age ≥75),
area-level characteristics (poverty rate >10 percent), hospital characteristics
(nonteaching hospital), tumor characteristics (advanced stage at diagnosis,
poor or undifferentiated tumors, colon vs rectal cancer), and treatment charac-
teristics (emergency surgery). Characteristics associated with lower odds of
death included being other race, diagnosis during 2005, and higher surgeon
case load. Characteristics not associated with odds of death included being
African American and Medicaid enrollment. Variability across census tracts
and hospitals remained evident in the multivariable model and was similar to
the unadjustedmodel based on the estimates of the variance and IOR, suggest-
ing that none of the measured variables were able to account for the observed
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Table 1: Sociodemographic, Hospital, Clinical, Tumor, and Treatment Vari-
ables Associated with Thirty-Day Mortality in Colorectal Cancer Patients Fol-
lowing Surgery, 2000–2005 (Unadjusted)
No. CRC Patients No. Deaths
30-day Mortality,
% (95%CI)
Sociodemographic characteristic
Sex*
Male 20,350 1,405 6.9 (6.6–7.3)
Female 27,101 1,721 6.4 (6.1–6.6)
Race*†
White 40,718 2,702 6.6 (6.4–6.9)
African American 3,644 270 7.4 (6.6–8.3)
Hispanic 725 42 5.8 (4.1–7.5)
Other 796 35 4.4 (3.0–5.8)
Asian 1,398 62 4.4 (3.4–5.5)
Comorbidity*
0 20,500 1,079 5.3 (5.0–5.6)
1 13,841 890 6.4 (6.0–6.8)
2+ 13,110 1,157 8.8 (8.3–9.3)
Medicaid (dual eligibility)*
Yes 7,809 630 8.1 (7.5–8.7)
No 39,642 2,496 6.3 (6.1–6.5)
Age group*
66–74 17,170 684 4.0 (3.7–4.3)
75–84 21,462 1,321 6.2 (5.8–6.5)
85+ 8,819 1,121 12.7 (12.0–13.4)
Year of diagnosis
2000 8,022 585 7.3 (6.7–7.9)
2001 7,972 531 6.7 (6.1–7.2)
2002 8,035 493 6.1 (5.6–6.7)
2003 8,169 548 6.7 (6.2–7.3)
2004 7,899 500 6.3 (5.8–6.9)
2005 7,354 469 6.4 (5.8–6.9)
Area-level characteristics
Poverty rate*
<10% 27,478 1,620 5.9 (5.6–6.2)
10–19% 12,048 874 7.3 (6.8–7.7)
20+% 7,677 615 8.0 (7.4–8.6)
Hospital characteristics
Hospital volume (beds)*
1–199 12,003 890 7.4 (7.0–7.9)
200–349 13,471 905 6.7 (6.3–7.1)
350–499 11,199 711 6.4 (5.9–6.8)
500+ 10,763 619 5.8 (5.3–6.2)
Surgeon case load*
<21 11,070 830 7.5 (7.0–8.0)
21–38 10,352 702 6.8 (6.3–7.3)
Continued
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Table 1. Continued
No. CRC Patients No. Deaths
30-day Mortality,
% (95%CI)
39–69 10,126 628 6.2 (5.7–6.7)
70+ 10,312 494 4.8 (4.4–5.2)
Unknown 5,581 472 8.5 (7.7–9.2)
Teaching hospital*
Yes 23,696 1,426 6.0 (5.7–6.3)
No 16,706 1,185 7.1 (6.7–7.5)
Unknown 7,049 515 7.3 (6.7–7.9)
Tumor characteristics
AJCC stage*
0/I 10,911 339 3.1 (2.8–3.4)
II 14,929 870 5.8 (5.5–6.2)
III 12,542 662 5.3 (4.9–5.7)
IV 6,468 976 15.1 (14.2–16.0)
Unknown 2,601 279 10.7 (9.5–11.9)
Tumor grade/differentiation*
Well 3,916 200 5.1 (4.4–5.8)
Moderate 30,397 1,680 5.5 (5.3–5.8)
Poor 9,307 809 8.7 (8.1–9.3)
Undifferentiated 507 59 11.6 (8.9–14.4)
Unknown 3,324 378 11.4 (10.3–12.5)
Tumor location*
Proximal colon 18,334 1,151 6.3 (5.9–6.6)
Transverse colon 7,039 563 8.0 (7.4–8.6)
Distal colon 12,734 929 7.3 (6.8–7.8)
Rectal 9,344 483 5.2 (4.7–5.6)
Tumor histology*
Mucinous adenocarcinoma 40,434 2,525 6.2 (6.0–6.5)
Other adenocarcinoma 5,967 418 7.0 (6.4–7.7)
Nonadenocarcinoma 1,050 183 17.4 (15.1–19.7)
Treatment characteristics
Emergency surgery*
Yes 11,845 1,518 12.8 (12.2–13.4)
No 35,606 1,608 4.5 (4.3–4.7)
Type of surgery*
Local tumor excision 962 50 5.2 (3.8–6.6)
Partial colectomy 18,690 1,049 5.6 (5.3–5.9)
Subtotal colectomy or hemicolectomy 22,603 1,363 6.0 (5.7–6.3)
Total (procto)colectomy 1,782 105 5.9 (4.8–7.0)
ColectomyNOS 955 91 9.5 (7.7–11.4)
Other surgery 187 16 8.6 (4.6–12.6)
Unknown surgery 2,227 452 19.9 (18.3–21.5)
*p < .01; CI, conﬁdence interval.
†Native American not included for conﬁdentiality reasons.
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variation across census tracts or hospitals (Table 4), although the ﬁt of the mul-
tivariable model was substantially better based on the reduction in the DIC.
Thus, while the ﬁxed effect of area-level poverty was associated with 30-day
mortality, this variable was unable to explain the geographic variation across
census tracts or hospitals. Figure 1 shows that the observed 30-day mortality
rate for 30 census tracts with at least 20 CRC patients ranged from 0.0 percent
to 15.0 percent (predicted rate range: 3.5–10.9 percent). For census tracts 1
through 16, the observed mortality rate was lower than predicted, suggesting
that CRC patients in these census tracts fared better than expected adjusting
for all variables in the multivariable model. In contrast, the observedmortality
rate for CRC patients in census tract 28 and 30 was higher than predicted,
suggesting that patients in these census tracts fared worse than expected.
The observed 30-day mortality rate for 30 hospitals with at least 20
CRC patients ranged from 0.0 percent to 12.9 percent (Figure 2). For hospitals
1 through 10, the observed mortality rate was lower than the predicted rate
based on the multivariable model (range: 3.8–9.3 percent), suggesting that
CRC patients in these hospitals fared better than expected adjusting for all
variables in the multivariable model. In contrast, the observed mortality rate
for CRC patients in hospitals 20, 22, 23, and 27 through 30 was higher than
predicted, suggesting that patients in these hospitals fared worse than
expected.
DISCUSSION
Our ﬁndings demonstrate an overall 30-day mortality rate of 6.6 percent that
is slightly higher than some studies (Schrag et al. 2000; Dekker et al. 2011),
Table 2: Unadjusted Variability in Thirty-Day Mortality across Patient Cen-
sus Tracts and Hospitals among Colorectal Cancer Patients Following Surgery
Census-Tract Variability Hospital Variability
Parameter 95% CI Parameter 95% CI
CRC
Variance 0.14 0.08–0.21 0.13 0.09–0.17
MOR 1.44 1.32–1.55 1.41 1.34–1.49
IOR 2.40 1.94–2.85 2.31 2.02–2.59
DIC 22,734
CI, credible interval; IOR, interquartile odds ratio; MOR,median odds ratio.
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Table 3: Adjusted Odds Ratio (95% Conﬁdence Interval) for Characteris-
tics Associated with Thirty-Day Mortality Following Colorectal Cancer Sur-
gery, 2000–2005
Adjusted OR
(95%CI)
Sociodemographic characteristics
Male sex (vs. female) 1.31 (1.21–1.42)
Race (vs. white)
African American 0.89 (0.77–1.04)
Other 0.67 (0.56–0.82)
Comorbidity (vs. 0)
1 1.17 (1.06–1.29)
2+ 1.60 (1.45–1.75)
Medicaid (yes vs. no) 1.06 (0.95–1.18)
Age group (vs. age 66–74)
75–84 1.65 (1.50–1.82)
85+ 3.53 (3.16–3.94)
Year at diagnosis (vs. 2000)
2001 0.95 (0.83–1.09)
2002 0.87 (0.76–1.00)
2003 0.97 (0.85–1.11)
2004 0.88 (0.77–1.01)
2005 0.86 (0.75–0.99)
Area-level characteristics
Poverty rate (vs. <10%)
10–19% 1.23 (1.12–1.36)
20+% 1.30 (1.15–1.47)
Hospital characteristics
Hospital volume (beds) versus 1–199 beds
200–349 0.91 (0.81–1.04)
350–499 0.94 (0.81–1.09)
500+ 0.86 (0.72–1.02)
Surgeon case load (vs. 70+)
<21 1.29 (1.13–1.47)
21–38 1.23 (1.07–1.41)
39–69 1.14 (0.99–1.31)
Unknown 1.19 (1.02–1.39)
Teaching hospital (vs. Yes)
No 1.15 (1.02–1.30)
Unknown 1.22 (1.05–1.42)
Tumor characteristics
AJCC stage (vs. 0/I)
II 1.60 (1.40–1.83)
III 1.46 (1.27–1.69)
IV 4.12 (3.57–4.75)
Unknown 1.65 (1.36–2.01)
Continued
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lower than others (Tekkis et al. 2003), and similar to other studies (Morris
et al. 2011; Panis et al. 2011). Our ﬁndings demonstrate that the location of
patient residence plays an important role in predicting 30-day mortality fol-
lowing CRC surgery. We observed that the variability across patient census
tracts was at least as large as across hospitals and that census-tract-level pov-
erty rate was associated with higher risk of death independent of hospital and
other characteristics included in the multivariable model. Thus, regardless of
the facility in which subjects were treated or the experience of the surgeon,
Table 3. Continued
Adjusted OR
(95%CI)
Tumor grade (vs. well differentiated)
Moderate differentiation 0.96 (0.82–1.12)
Poor differentiation 1.35 (1.14–1.60)
Undifferentiated 1.75 (1.25–2.45)
Unknown 1.26 (1.03–1.55)
Tumor location (vs. rectal)
Proximal colon 1.41 (1.25–1.60)
Transverse colon 1.57 (1.36–1.82)
Distal colon 1.28 (1.11–1.46)
Tumor histology (vs. mucinous adenocarcinoma)
Nonadenocarcinoma/unknown 1.63 (1.31–2.01)
Other CRC 1.00 (0.88–1.12)
Treatment characteristics
Emergency surgery (vs. No) 2.35 (2.17–2.55)
Table 4: Adjusted Variability in Thirty-Day Mortality across Patient Census
Tracts and Hospitals among Colorectal Cancer Patients Following Surgery
Census-Tract Variability Hospital Variability
Parameter 95% CI Parameter 95% CI
CRC
Variance 0.18 0.11–0.25 0.12 0.08–0.15
MOR 1.50 1.38–1.62 1.38 1.31–1.45
IOR 2.68 2.17–3.19 2.18 1.92–2.44
DIC 20,173
Adjusted for sociodemographic, hospital, tumor, and treatment characteristics. CI, credible
interval; IOR, interquartile odds ratio; MOR,median odds ratio.
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and independent tumor and patient characteristics, CRC patients had an
increased risk of death if they lived in areas with worse economic conditions.
While some studies have shown the adverse effects of living in economically
deprived areas on CRC survival (Hole and McArdle 2002), ours is the ﬁrst
population-based study in the United States that showed this to be the case for
30-day mortality after CRC surgery. This ﬁnding suggests that where patients
live affects their short-term mortality risk. CRC patients in some census tracts
had higher mortality than expected while other census tracts had lower than
expected 30-day mortality. Because none of the variables, including census-
tract poverty, included in the model was able to entirely explain the geo-
graphic variability in the independent effect of census-tract poverty rate on
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Figure 1: Observed and Predicted Variability in Thirty-Day Mortality
Based on SEER-Medicare Data from 2000 to 2005 across the Thirty Census
Tracts with at Least Twenty CRC Patients Based on theMultivariableModel
Note. Predicted 30-day mortality, based on the multilevel logistic regression model adjusted for
sociodemographic, census-tract, hospital, clinical, tumor, and treatment characteristics, are plotted
as circles above the encrypted census tract identiﬁers along the horizontal axis. Error bars indicate
95 percent conﬁdence intervals. Census-tract-level predicted values were computed by averaging
the patient-level predicted probabilities for all patients who resided in that census tract. Census
tracts 1 through 12 had zero observed deaths; thus, there is no bar associated with these census
tracts.
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30-day mortality, intervening upon variables included in the model would not
be expected to reduce the geographic variability in 30-day mortality.
It is not known why living in an economically deprived area would
increase the 30-day mortality risk even after controlling for hospital and clini-
cal factors. Identifying the causes of this geographic variability and ﬁnding
ways to minimize this risk could increase our ability to improve outcomes fol-
lowing CRC surgery. One potential mechanism could be that patients living
in economically deprived areas are more likely to experience environmental
stress resulting in systemic inﬂammation, to be obese, to have low levels of
vitamin D, or to smoke, all of which have been shown to affect long-term
survival following CRC diagnosis (McMillan, Canna, and McArdle 2003;
Dignam et al. 2006; Freedman et al. 2007; Roxburgh et al. 2011).
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Figure 2: Observed and Predicted Variability in Thirty-Day Mortality Based
on SEER-Medicare Data from 2000 to 2005 across a Random Sample of Thirty
Hospitals with at Least Twenty CRCPatients Based on theMultilevelModel
Note. Predicted 30-day mortality, based on the multilevel logistic regression model adjusted for so-
ciodemographic, hospital, clinical, tumor, and treatment characteristics, are plotted as circles
above the encrypted hospital identiﬁers along the horizontal axis. Error bars indicate 95 percent
conﬁdence intervals. Hospital-level predicted values were computed by averaging the patient-
level predicted probabilities for all patients who were treated at that hospital. Hospitals 1 through
5 had zero observed deaths; thus, there is no bar associated with any of these hospitals.
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Unfortunately, information regarding these exposures was not available in the
SEER-Medicare data.
An alternative mechanism could be that those living in economically
deprived areas have less access to social or medical services such as nearby
primary care facilities, timely transportation to necessary follow-up appoint-
ments or for urgent medical conditions, or basic home-health or social services
that could support immobile or low-functioning patients. Previous studies also
have shown that patients with lower preoperative physical status measured
using the American Society of Anesthesiologists (ASA) Score (Owens, Felts,
and Spitznagel 1978) had increased 30-day mortality risk (Longo et al. 2000;
Cohen et al. 2009; Al-Refaie et al. 2011), but ASA scores were unavailable in
the SEER-Medicare data. However, we included comorbidity in our models,
which may relate to 30-day mortality in a similar fashion, because comorbidi-
ty and physical status are correlated (Smith et al. 2008; Deshpande et al.
2011). Thus, while a unifying explanation is yet to emerge, our ﬁndings
emphasize the importance of identifying the observed variability in 30-day
mortality across geographic areas in order to intervene upon modiﬁable risk
factors that can optimize patient outcomes.
Our ﬁndings also show that 30-day mortality varied across hospitals,
regardless of patient sociodemographic, area-level characteristics, clinical
factors, tumor characteristics, type of treatment received, and hospital char-
acteristics. CRC patients in some hospitals fared worse than expected while
others fared better. Similar to other studies (Meyerhardt et al. 2003; Billingsley
et al. 2007; Iversen et al. 2007), we observed that patients treated at hospi-
tals with higher patient volumes or at teaching hospitals had lower risk of
death. While patients treated at these hospitals had decreased mortality,
neither the hospital characteristics nor the surgeon case load explained the
variation as described by the MOR. Billingsley (Billingsley et al. 2007)
suggested the availability of sophisticated clinical services that facilitate the
timely management of medical or surgical complications explained why
high-volume hospitals have better outcomes following CRC surgery. Previ-
ous studies have suggested that “failure to rescue,” that is, mortality among
patients with major complications, may be an important mechanism under-
lying hospital mortality associated with surgery (Silber et al. 1992; Ghaferi
and Dimick 2012) and may help explain remaining variability among hospi-
tals. Multilevel observational studies, such as ours, may be used to monitor
such variation across levels such as hospitals and geographic regions. Such
methods may serve as important future methods for quality measurement of
cancer care.
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Our results should be interpreted with the understanding that our sample
included only fee-for-serviceMedicare-insured patients, limiting generalizabil-
ity to younger patients or to uninsured or privately insured patients. Because
hospital size and location are closely related, we were unable to ascertain the
independent effect of urban–rural hospital location. Strengths of our study
include integrating a large number of patient, tumor, clinical, hospital, and
treatment factors into one analytic model that simultaneously estimated both
hospital and geographic variability using a multilevel cross-classiﬁed model.
Additionally, unlike previous studies that only looked at the ﬁxed effects of
hospital characteristics, our study used a random term (median odds ratio) to
describe the variability across hospitals. This approach is starting to gain popu-
larity because, unlike ﬁxed effects, it can quantify the extent of the variability
in health outcomes across different “levels” (e.g., hospitals, surgeons, or neigh-
borhoods; Lian et al. 2011; McCahill et al. 2012). However, our analysis does
not take into account the spatial relationship between adjacent census tracts.
Future research may use such methods to identify where 30-day mortality was
concentrated spatially using geographically weighted regressionmethods.
In conclusion, census-tract and hospital variation was observed in
30-day mortality following CRC surgery in patients 66 years of age and older
that was not explained by patient sociodemographic, clinical, tumor, treat-
ment, or hospital characteristics. Risk of 30-day mortality is driven by these
individual-level characteristics and by both hospital-level and area-level
social, economic, and organizational factors that distinguish different hospitals
and geographic areas.
ACKNOWLEDGMENTS
Joint Acknowledgment/Disclosure Statement: This study was supported by grants
from the National Cancer Institute at the National Institutes of Health (grant
number CA112159); and the Health Behavior, Communication and Outreach
Core; the Core is supported in part by the National Cancer Institute Cancer
Center Support Grant (grant number P30 CA91842) to the Alvin J. Siteman
Cancer Center at Washington University School of Medicine and Barnes-Jew-
ish Hospital in St. Louis, Missouri. NODwas supported in part through grants
HL-38180, DK-56260, and Digestive Disease Research Core Center
DK-52574.
Disclosures: None.
Disclaimers: None.
1160 HSR: Health Services Research 49:4 (August 2014)
REFERENCES
Al-Refaie, W. B., H. M. Parsons, E. B. Habermann, M. Kwaan, M. P. Spencer, W. G.
Henderson, and D. A. Rothenberger. 2011. “Operative Outcomes Beyond 30-
day Mortality: Colorectal Cancer Surgery in Oldest Old.” Annals of Surgery 253
(5): 947–52.
American Cancer Society. 2012. Cancer Facts & Figures, 2012. Atlanta, GA: American
Cancer Society.
Billingsley, K. G., A. M. Morris, J. A. Dominitz, B. Matthews, S. Dobie, W. Barlow, G.
E. Wright, and L. M. Baldwin. 2007. “Surgeon and Hospital Characteristics as
Predictors of Major Adverse Outcomes Following Colon Cancer Surgery:
Understanding the Volume-Outcome Relationship.” Archives of Surgery 142 (1):
23–31; discussion 32.
Centers for Medicare & Medicaid Services. 2011. “Medicare Program; Hospital Inpa-
tient Value-Based Purchasing Program. Final Rule.” Federal Register 76 (88):
26490–547.
Cohen, M. E., K. Y. Bilimoria, C. Y. Ko, and B. L. Hall. 2009. “Development of an
American College of Surgeons National Surgery Quality Improvement Pro-
gram: Morbidity and Mortality Risk Calculator for Colorectal Surgery.” Journal
of the American College of Surgeons 208 (6): 1009–16.
Davila, J., L. Rabeneck, D. Berger, and H. El-Serag. 2005. “Postoperative 30-day Mor-
tality Following Surgical Resection for Colorectal Cancer in Veterans: Changes
in the Right Direction.”Digestive Diseases and Sciences 50 (9): 1722–8.
Dekker, J., C. van den Broek, E. Bastiaannet, L. van de Geest, R. Tollenaar, and G. Lie-
fers. 2011. “Importance of the First Postoperative Year in the Prognosis of
Elderly Colorectal Cancer Patients.” Annals of Surgical Oncology 18 (6): 1533–9.
Deshpande, A. D., J. A. Sefko, D. B. Jeffe, and M. Schootman. 2011. “The Association
between Chronic Disease Burden and Quality of Life among Breast Cancer Sur-
vivors in Missouri.” Breast Cancer Research 129 (3): 877–86. PMCID:
PMC3250926.
Dignam, J. J., B. N. Polite, G. Yothers, P. Raich, L. Colangelo, M. J. O’Connell, and N.
Wolmark. 2006. “Body Mass Index and Outcomes in Patients Who Receive
Adjuvant Chemotherapy for Colon Cancer.” Journal of the National Cancer Insti-
tute 98 (22): 1647–54.
Donabedian, A. 1988. “The Quality of Care: How Can It Be Assessed?” Journal of the
American Medical Association 260 (12): 1743–8.
Fazio, V. W., P. P. Tekkis, F. Remzi, and I. C. Lavery. 2004. “Assessment of Operative
Risk in Colorectal Cancer Surgery: The Cleveland Clinic Foundation Colorectal
CancerModel.”Diseases of the Colon and Rectum 47 (12): 2015–24.
Freedman, D. M., A. C. Looker, S.-C. Chang, and B. I. Graubard. 2007. “Prospective
Study of SerumVitamin D and Cancer Mortality in the United States.” Journal of
the National Cancer Institute 99 (21): 1594–602.
Ghaferi, A. A., and J. B. Dimick. 2012. “Variation in Mortality after High-Risk Cancer
Surgery: Failure to Rescue.” Surgical Oncology Clinics of North America 21 (3): 389–
95, vii.
Variability in Thirty-Day Mortality 1161
Hodgson, D. C., C. S. Fuchs, and J. Z. Ayanian. 2001. “Impact of Patient and Provider
Characteristics on the Treatment andOutcomes of Colorectal Cancer.” Journal of
the National Cancer Institute 93 (7): 501–15.
Hole, D., and C. McArdle. 2002. “Impact of Socioeconomic Deprivation on Outcome
after Surgery for Colorectal Cancer.” British Journal of Surgery 89 (5): 586–90.
Institute of Medicine. 1999. Ensuring Quality Cancer Care. Washington, DC: National
Academy Press.
Iversen, L. H., H. Harling, S. Laurberg, and P. Wille-Jorgensen. 2007. “Inﬂuence of
Caseload and Surgical Speciality on Outcome Following Surgery for Colorectal
Cancer: A Review of Evidence. Part 1: Short-Term Outcome.” Colorectal Disease
9 (1): 28–37.
Lian, M., M. Schootman, C. A. Doubeni, Y. Park, J. M. Major, R. A. Torres Stone,
A. O. Laiyemo, A. R. Hollenbeck, B. I. Graubard, and A. Schatzkin. 2011.
“Geographic Variation in Colorectal Cancer Survival and the Role of Small-
Area Socioeconomic Deprivation: A Multilevel Survival Analysis of the NIH-
AARP Diet and Health Study Cohort.” American Journal of Epidemiology 174
(7): 828–38.
Longo, W., K. Virgo, F. Johnson, C. Oprian, A. Vernava, T. Wade, M. Phelan,
W. Henderson, J. Daley, and S. Khuri. 2000. “Risk Factors for Morbidity and
Mortality after Colectomy for Colon Cancer.” Diseases of the Colon & Rectum 43
(1): 83–91.
McCahill, L. E., R. M. Single, E. J. Aiello Bowles, H. S. Feigelson, T. A. James,
T. Barney, J. M. Engel, and A. A. Onitilo. 2012. “Variability in Reexcision
Following Breast Conservation Surgery.” The Journal of the American Medical
Association 307 (5): 467–75.
McMillan, D. C., K. Canna, and C. S. McArdle. 2003. “Systemic Inﬂammatory
Response Predicts Survival Following Curative Resection of Colorectal Cancer.”
British Journal of Surgery 90 (2): 215–9.
Merlo, J., B. Chaix, H. Ohlsson, A. Beckman, K. Johnell, P. Hjerpe, L. Rastam, and K.
Larsen. 2006. “A Brief Conceptual Tutorial of Multilevel Analysis in Social Epi-
demiology: Using Measures of Clustering in Multilevel Logistic Regression to
Investigate Contextual Phenomena.” Journal of Epidemiology and Community
Health 60 (4): 290–7.
Meyerhardt, J. A., P. J. Catalano, D. Schrag, J. Z. Ayanian, D. G. Haller, R. J. Mayer, J.
S. Macdonald, A. B. Benson 3rd, and C. S. Fuchs. 2003. “Association of Hospital
Procedure Volume and Outcomes in Patients with Colon Cancer at High Risk
for Recurrence.” Annals of Internal Medicine 139 (8): 649–57.
Moller, H., F. Sandin, D. Robinson, F. Bray, ~A. s. Klint, K. M. Linklater, P. C. Lambert,
L. P~A¥hlman, L. Holmberg, and E. Morris. 2011. “Colorectal Cancer Survival
in Socioeconomic Groups in England: Variation is Mainly in the Short Term
after Diagnosis.” European Journal of Cancer 48 (1): 46–53.
Morris, E. J., E. F. Taylor, J. D. Thomas, P. Quirke, P. J. Finan, M. P. Coleman, B.
Rachet, and D. Forman. 2011. “Thirty-Day Postoperative Mortality after Colo-
rectal Cancer Surgery in England.”Gut 60 (6): 806–13.
1162 HSR: Health Services Research 49:4 (August 2014)
National Cancer Institute. 2011. “SEER-Medicare: Calculation of Comorbidity
Weights” [accessed on July 17, 2011, 2013]. Available at http://healthservices.
cancer.gov/seermedicare/program/comorbidity.html
Owens, W. D., J. A. Felts, and E. L. Spitznagel Jr. 1978. “ASA Physical Status Classiﬁca-
tions: A Study of Consistency of Ratings.” Anesthesiology 49 (4): 239–43.
Panis, Y., L. Maggiori, G. Caranhac, F. Bretagnol, and E. Vicaut. 2011. “Mortality after
Colorectal Cancer Surgery: A French Survey of More Than 84,000 Patients.”
Annals of Surgery 254 (5): 738–43; discussion 43–4.
Polite, B. N., J. J. Dignam, and O. I. Olopade. 2006. “Colorectal Cancer Model of
Health Disparities: Understanding Mortality Differences in Minority Popula-
tions.” Journal of Clinical Oncology 24 (14): 2179–87.
Roxburgh, C., J. Platt, E. Leitch, J. Kinsella, P. Horgan, and D. McMillan. 2011. “Rela-
tionship between Preoperative Comorbidity, Systemic Inﬂammatory Response,
and Survival in Patients Undergoing Curative Resection for Colorectal Cancer.”
Annals of Surgical Oncology 18 (4): 997–1005.
Schrag, D., L. D. Cramer, P. B. Bach, A. M. Cohen, J. L.Warren, and C. B. Begg. 2000.
“Inﬂuence of Hospital Procedure Volume on Outcomes Following Surgery for
Colon Cancer.” Journal of the American Medical Association 284 (23): 3028–35.
Schrag, D., K. S. Panageas, E. Riedel, L. Hsieh, P. B. Bach, J. G. Guillem, and C. B.
Begg. 2003. “Surgeon Volume Compared to Hospital Volume as a Predictor of
Outcome Following Primary Colon Cancer Resection.” Journal of Surgical Oncol-
ogy 83 (2): 68–78.
Silber, J. H., S. V. Williams, H. Krakauer, and J. S. Schwartz. 1992. “Hospital and
Patient Characteristics Associated with Death after Surgery: A Study of Adverse
Occurrence and Failure to Rescue.”Medical Care 30 (7): 615–29.
Smith,A.W.,B.B.Reeve,K.M.Bellizzi, L.C.Harlan,C.N.Klabunde,M.Amsellem,A.
S. Bierman, and R. D. Hays. 2008. “Cancer, Comorbidities, and Health-Related
QualityofLife ofOlderAdults.”HealthCareFinancingReview29 (4): 41–56.
Snijders, T. A. B., and R. J. Bosker. 1999. Multilevel Analysis. An Introduction to Basic and
Advanced Multilevel Modeling. London: Sage Publications.
Tanenbaum, S. J. 2013. “Reducing Variation in Health Care: The Rhetorical Politics of
a Policy Idea.” Journal of Health Politics, Policy and Law 38 (1): 5–26.
Tekkis, P. P., J. D. Poloniecki, M. R. Thompson, and J. D. Stamatakis. 2003. “Operative
Mortality in Colorectal Cancer: Prospective National Study.” British Medical Jour-
nal 327 (7425): 1196–201.
Warren, J. L.,C.N.Klabunde,D. Schrag, P. B. Bach, andG. F.Riley. 2002. “Overviewof
the SEER-Medicare Data: Content, Research Applications, and Generalizability
to theUnitedStatesElderlyPopulation.”MedicalCare40 (8Suppl): IV–3–18.
Warren, J. L., K. R. Yabroff, A. Meekins, M. Topor, E. B. Lamont, and M. L. Brown.
2008. “Evaluation of Trends in the Cost of Initial Cancer Treatment.” Journal of
the National Cancer Institute 100 (12): 888–97.
Wennberg, J. 1999. “Understanding Geographic Variations in Health Care Delivery.”
New England Journal of Medicine 340: 52–3.
Wennberg, D. E. 2010. Tracking Medicine: A Researcher’s Quest to Understand Health Care.
Oxford, UK: Oxford University Press.
Variability in Thirty-Day Mortality 1163
SUPPORTING INFORMATION
Additional supporting information may be found in the online version of this
article:
Appendix SA1: AuthorMatrix.
1164 HSR: Health Services Research 49:4 (August 2014)
